Pyxus International AI Stock Analysis
Want to see PYYX full AI Analyst Report?
Pyxus International (PYYX) AI Stock Analysis
Pyxus International
(Other OTC:PYYX)
The overall score is heavily constrained by a precarious financial foundation, marked by extreme leverage and negative cash flows, which overshadows the positive developments. The primary support comes from a confident earnings call where management outlined a clear path to improved second-half performance, backed by committed inventory and better margins. However, the bearish technical trend and a valuation that signals a value trap rather than an opportunity reinforce the high-risk nature of the stock.
Pyxus International (PYYX) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $62.01M
- Dividend Yield
- ―
- Average Volume (3M)
- 6,130
- Price to Earnings (P/E)
- 2.3
- Beta (1Y)
- 0.27
- Revenue Growth
- -2.24%
- EPS Growth
- ―
- Country
- US
- Employees
- 3,300
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Pyxus International Business Overview & Revenue Model
Company Description
Pyxus International, Inc. operates as an agricultural enterprise, delivering specialized products and services to a diverse range of business and individual clients. A core part of its operations involves managing the entire supply chain for tobacco...
Pyxus International Earnings Call Summary
The call was predominantly positive. Although first-half sales and adjusted EBITDA declined because of shipment timing, lower volumes, delayed processing, and logistics and power disruptions, management highlighted stronger leaf margins, lower-cost committed inventory, materially improved cash generation, better credit metrics, a return to quarterly net income, reaffirmed sales guidance, and a tightened adjusted EBITDA range. Management expressed confidence in a strong second half and in the planned capital structure transaction.
Q2-2027 Updates
Positive Updates
Negative Updates
Company Guidance
For fiscal year 2027, the company is reaffirming full year sales guidance of $2.3 billion to $2.5 billion and tightening full year adjusted EBITDA guidance to $215 million to $235 million, supported by nearly 95% of processed inventory committed, lower cost committed inventory, and significantly higher shipment activity in the second half; management said, “We anticipate a strong second half,” has the inventory and plans in place to meet guidance, and is feeling confident “unless something really unusual happens.”
Pyxus International Financial Statement Overview
Summary
Financial health is critically weak. While margins have improved and the company returned to marginal net income, the TTM revenue decline of 24.3%, extreme debt-to-equity of 7.8x, and deeply negative operating and free cash flow present a high-risk profile. The inability to convert profits into cash is a major red flag.
Income Statement
35NegativeBalance Sheet
20Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.31B | 2.41B | 2.48B | 2.03B | 1.91B | 1.64B |
| Gross Profit | 341.44M | 332.30M | 342.98M | 312.33M | 261.02M | 227.06M |
| EBITDA | 187.17M | 196.73M | 181.83M | 160.18M | 117.20M | 45.70M |
| Net Income | 28.14M | 14.57M | 15.17M | 2.66M | -56.75M | -92.00M |
Balance Sheet | ||||||
| Total Assets | 2.05B | 1.69B | 1.50B | 1.66B | 1.58B | 1.70B |
| Cash, Cash Equivalents and Short-Term Investments | 96.57M | 134.34M | 78.25M | 92.57M | 136.73M | 198.78M |
| Total Debt | 1.38B | 963.82M | 877.99M | 1.05B | 1.04B | 1.10B |
| Total Liabilities | 1.87B | 1.51B | 1.34B | 1.51B | 1.44B | 1.52B |
| Stockholders Equity | 172.09M | 174.49M | 160.09M | 142.28M | 137.85M | 175.28M |
Cash Flow | ||||||
| Free Cash Flow | -153.33M | -230.50M | -36.41M | -236.01M | -154.13M | -213.59M |
| Operating Cash Flow | -129.23M | -208.45M | -13.39M | -214.97M | -137.82M | -198.76M |
| Investing Cash Flow | 147.54M | 191.42M | 170.64M | 159.45M | 154.94M | 181.24M |
| Financing Cash Flow | -20.70M | 72.52M | -167.26M | 25.56M | -83.00M | 123.26M |
Pyxus International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PYYX, the sentiment is Neutral. The current price of 2.52 is above the 20-day moving average (MA) of 2.49, below the 50-day MA of 2.74, and below the 200-day MA of 2.97, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 46.78 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PYYX.
Pyxus International Peers Comparison
Overall Rating
BTI68Neutral
PM68Neutral
MO65Neutral
TPB59Neutral
PYYX47Neutral
UVV42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | $132.16B | 15.95 | 13.38% | 5.34% | 4.47% | 117.22% | |
| 68Neutral | $310.11B | 29.05 | -119.68% | 3.02% | 7.91% | 24.06% | |
| 65Neutral | $130.81B | 16.25 | -279.72% | 5.46% | 2.41% | -7.63% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 59Neutral | $1.10B | 39.12 | 6.97% | 0.57% | 23.78% | -51.37% | |
| 47Neutral | $62.01M | 2.31 | 16.66% | ― | -2.24% | ― | |
| 42Neutral | $941.49M | -377.70 | -0.17% | 8.74% | -8.88% | -102.19% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PYYX | Pyxus International Inc | 2.52 | -1.38 | -35.38% | |
| MO | Altria | 78.64 | 24.19 | 44.43% | |
| BTI | British American Tobacco | 61.89 | 10.25 | 19.86% | |
| PM | Philip Morris International | 198.96 | 51.42 | 34.85% | |
| UVV | Universal Corporation | 37.77 | -11.04 | -22.62% | |
| TPB | Turning Point Brands Inc | 55.55 | -44.97 | -44.74% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
